266 related articles for article (PubMed ID: 30706688)
61. Lobe-Specific Nodal Dissection for Clinical Stage I and II NSCLC: Japanese Multi-Institutional Retrospective Study Using a Propensity Score Analysis.
Hishida T; Miyaoka E; Yokoi K; Tsuboi M; Asamura H; Kiura K; Takahashi K; Dosaka-Akita H; Kobayashi H; Date H; Tada H; Okumura M; Yoshino I;
J Thorac Oncol; 2016 Sep; 11(9):1529-37. PubMed ID: 27249959
[TBL] [Abstract][Full Text] [Related]
62. Time trend of mediastinal lymph node dissection in stage IA non-small cell lung cancer patient who undergo lobectomy: a retrospective study of surveillance, epidemiology, and end results (SEER) database.
Pan L; Mo R; Zhu L; Yu W; Lv W; Hu J
J Cardiothorac Surg; 2020 Aug; 15(1):207. PubMed ID: 32738925
[TBL] [Abstract][Full Text] [Related]
63. Visceral pleural invasion in T1 tumors (≤3 cm), particularly T1a, in the eighth tumor-node-metastasis classification system for non-small cell lung cancer: a population-based study.
Zhang T; Zhang JT; Li WF; Lin JT; Liu SY; Yan HH; Yang JJ; Yang XN; Wu YL; Nie Q; Zhong WZ
J Thorac Dis; 2019 Jul; 11(7):2754-2762. PubMed ID: 31463103
[TBL] [Abstract][Full Text] [Related]
64. Effect of Adjuvant Chemotherapy on Survival of Patients With 8th Edition Stage IB Non-Small Cell Lung Cancer.
Xu Y; Wan B; Zhu S; Zhang T; Xie J; Liu H; Zhan P; Lv T; Song Y
Front Oncol; 2021; 11():784289. PubMed ID: 35155190
[TBL] [Abstract][Full Text] [Related]
65. The significance of visceral pleural surface invasion in 321 cases of non-small cell lung cancers with pleural retraction.
Chang YL; Lin MW; Shih JY; Wu CT; Lee YC
Ann Surg Oncol; 2012 Sep; 19(9):3057-64. PubMed ID: 22492226
[TBL] [Abstract][Full Text] [Related]
66. The importance of lymph node dissection accompanying wedge resection for clinical stage IA lung cancer.
Stiles BM; Kamel MK; Nasar A; Harrison S; Nguyen AB; Lee P; Port JL; Altorki NK
Eur J Cardiothorac Surg; 2017 Mar; 51(3):511-517. PubMed ID: 28007869
[TBL] [Abstract][Full Text] [Related]
67. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome.
Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK
Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680
[TBL] [Abstract][Full Text] [Related]
68. Diagnostic performance and prognostic value of CT-defined visceral pleural invasion in early-stage lung adenocarcinomas.
Lim WH; Lee KH; Lee JH; Park H; Nam JG; Hwang EJ; Chung JH; Goo JM; Park S; Kim YT; Kim H
Eur Radiol; 2024 Mar; 34(3):1934-1945. PubMed ID: 37658899
[TBL] [Abstract][Full Text] [Related]
69. Prognostic relevance of pleural invasion for resected NSCLC patients undergoing adjuvant treatments: A propensity score-matched analysis of SEER database.
De Giglio A; Di Federico A; Gelsomino F; Ardizzoni A
Lung Cancer; 2021 Nov; 161():18-25. PubMed ID: 34492552
[TBL] [Abstract][Full Text] [Related]
70. Lymph node dissection and survival in patients with early stage nonsmall cell lung cancer: A 10-year cohort study.
Shen-Tu Y; Mao F; Pan Y; Wang W; Zhang L; Zhang H; Cheng B; Guo H; Wang Z
Medicine (Baltimore); 2017 Oct; 96(43):e8356. PubMed ID: 29069017
[TBL] [Abstract][Full Text] [Related]
71. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
[TBL] [Abstract][Full Text] [Related]
72. Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer.
Shimizu K; Yoshida J; Nagai K; Nishimura M; Ishii G; Morishita Y; Nishiwaki Y
J Thorac Cardiovasc Surg; 2005 Jul; 130(1):160-5. PubMed ID: 15999057
[TBL] [Abstract][Full Text] [Related]
73. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
[TBL] [Abstract][Full Text] [Related]
74. Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer.
Saji H; Tsuboi M; Yoshida K; Kato Y; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
J Thorac Oncol; 2011 Nov; 6(11):1865-71. PubMed ID: 21964529
[TBL] [Abstract][Full Text] [Related]
75. Visceral pleural invasion is not a significant prognostic factor in patients with a part-solid lung cancer.
Hattori A; Suzuki K; Matsunaga T; Takamochi K; Oh S
Ann Thorac Surg; 2014 Aug; 98(2):433-8. PubMed ID: 24961845
[TBL] [Abstract][Full Text] [Related]
76. Extent of lymph node resection does not increase perioperative morbidity and mortality after surgery for stage I lung cancer in the elderly.
Shapiro M; Mhango G; Kates M; Weiser TS; Chin C; Swanson SJ; Wisnivesky JP
Eur J Surg Oncol; 2012 Jun; 38(6):516-22. PubMed ID: 22244908
[TBL] [Abstract][Full Text] [Related]
77. Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non-small cell lung cancer.
Zhang P; Duan J; Bai H; Wang Z; Gao S; Tan F; Gao Y; Wang X; Wan R; Xu J; He X; Feng X; Yu R; Sun J; Zhao Z; Fei K; Li N; He J; Wang J
Thorac Cancer; 2021 Jan; 12(1):30-39. PubMed ID: 33111432
[TBL] [Abstract][Full Text] [Related]
78. Does the extent of lymph nodes dissection affect the prognosis of resected stage IA non-small cell lung cancer?
Xu F; Wang C; Qi L; Yu W; Li Q
Clin Transl Oncol; 2014 Jan; 16(1):77-84. PubMed ID: 23615980
[TBL] [Abstract][Full Text] [Related]
79. Clinical significance of visceral pleural and lymphovascular invasion in surgically resected adenosquamous lung cancer.
Wang Y; Qian F; Hu M; Chen Y; Yang Z; Han B
Eur J Cardiothorac Surg; 2021 Apr; 59(3):617-623. PubMed ID: 33200178
[TBL] [Abstract][Full Text] [Related]
80. The eighth TNM classification system for lung cancer: A consideration based on the degree of pleural invasion and involved neighboring structures.
Sakakura N; Mizuno T; Kuroda H; Arimura T; Yatabe Y; Yoshimura K; Sakao Y
Lung Cancer; 2018 Apr; 118():134-138. PubMed ID: 29571992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
